Global Antiviral Drugs Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

Description

List of Tables

The global demand for Antiviral Drugs Market is presumed to reach the market size of nearly USD 101.14 Billion by 2032 from USD 80 Billion in 2023 with a CAGR of 2.64% under the study period 2024-2032.

Antiviral drugs are the one which specifically is used to treat viral infectious disease. Unlike antibiotic, antiviral do not kill the target pathogen rather they stop the development of the pathogen. Even there are few listed natural antiviral which is produced by plants, eucalyptus is one of those. Researchers are working on extending the range of antiviral drugs to meet the growing need of the product owing to the rising incidence of viral diseases around the world.

MARKET DYNAMICS

The market of antiviral drugs is growing mainly on the ground of rising prevalence of infectious disease along with the presence of strong pipeline of the product. The rise in competition among the manufacturer for the development of novel drugs is also likely to enhance the market of the antiviral drugs. Also, increasing STD's disease and growing awareness among the people for early and efficient treatment is also projected to raise the demand for the product along with the increasing healthcare expenditure, will boost the growth of the market. However, the high cost of the drugs is likely to restrain the market growth.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Antiviral Drugs. The growth and trends of Antiviral Drugs industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Antiviral Drugs market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Type Scope

Branded
Generics

By Drug Class Scope

DNA Polymerase Inhibitors
Reverse Transcriptase Inhibitors
Protease Inhibitors
Neuraminidase Inhibitors
Others

By Distribution Channel Scope

Hospital Pharmacy
Retail Pharmacy
Online Pharmacy

By Application Scope

HIV
Hepatitis
Herpes
Influenza
Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Antiviral Drugs market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Antiviral Drugs market include F. Hoffmann-La Roche Ltd., GSK Plc, AbbVie Inc., Merck & Co. Inc., Johnson & Johnson Services Inc., Bristol-Myers Squibb Company, Cipla Inc., Aurobindo Pharma, Dr. Reddy'S Laboratories Ltd. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

Product Code: VMR11211443

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. ANTIVIRAL DRUGS - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Type Scope
- 3.7.2 Market Attractiveness Analysis By Drug Class Scope
- 3.7.3 Market Attractiveness Analysis By Distribution Channel Scope
- 3.7.4 Market Attractiveness Analysis By Application Scope
- 3.7.5 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL ANTIVIRAL DRUGS MARKET ANALYSIS BY TYPE SCOPE

5.1. Overview By Type Scope
5.2. Historical and Forecast Data
5.3. Analysis By Type Scope
5.4. Branded Historic and Forecast Sales By Regions
5.5. Generics Historic and Forecast Sales By Regions

6. GLOBAL ANTIVIRAL DRUGS MARKET ANALYSIS BY DRUG CLASS SCOPE

6.1. Overview By Drug Class Scope
6.2. Historical and Forecast Data
6.3. Analysis By Drug Class Scope
6.4. DNA Polymerase Inhibitors Historic and Forecast Sales By Regions
6.5. Reverse Transcriptase Inhibitors Historic and Forecast Sales By Regions
6.6. Protease Inhibitors Historic and Forecast Sales By Regions
6.7. Neuraminidase Inhibitors Historic and Forecast Sales By Regions
6.8. Others Historic and Forecast Sales By Regions

7. GLOBAL ANTIVIRAL DRUGS MARKET ANALYSIS BY DISTRIBUTION CHANNEL SCOPE

7.1. Overview By Distribution Channel Scope
7.2. Historical and Forecast Data
7.3. Analysis By Distribution Channel Scope
7.4. Hospital Pharmacy Historic and Forecast Sales By Regions
7.5. Retail Pharmacy Historic and Forecast Sales By Regions
7.6. Online Pharmacy Historic and Forecast Sales By Regions

8. GLOBAL ANTIVIRAL DRUGS MARKET ANALYSIS BY APPLICATION SCOPE

8.1. Overview By Application Scope
8.2. Historical and Forecast Data
8.3. Analysis By Application Scope
8.4. HIV Historic and Forecast Sales By Regions
8.5. Hepatitis Historic and Forecast Sales By Regions
8.6. Herpes Historic and Forecast Sales By Regions
8.7. Influenza Historic and Forecast Sales By Regions
8.8. Others Historic and Forecast Sales By Regions

9. GLOBAL ANTIVIRAL DRUGS MARKET ANALYSIS BY GEOGRAPHY

9.1. Regional Outlook
9.2. Introduction
9.3. North America Sales Analysis
- 9.3.1 Overview, Historic and Forecast Data Sales Analysis
- 9.3.2 North America By Segment Sales Analysis
- 9.3.3 North America By Country Sales Analysis
- 9.3.4 United States Sales Analysis
- 9.3.5 Canada Sales Analysis
- 9.3.6 Mexico Sales Analysis
9.4. Europe Sales Analysis
- 9.4.1 Overview, Historic and Forecast Data Sales Analysis
- 9.4.2 Europe By Segment Sales Analysis
- 9.4.3 Europe By Country Sales Analysis
- 9.4.4 United Kingdom Sales Analysis
- 9.4.5 France Sales Analysis
- 9.4.6 Germany Sales Analysis
- 9.4.7 Italy Sales Analysis
- 9.4.8 Russia Sales Analysis
- 9.4.9 Rest Of Europe Sales Analysis
9.5. Asia Pacific Sales Analysis
- 9.5.1 Overview, Historic and Forecast Data Sales Analysis
- 9.5.2 Asia Pacific By Segment Sales Analysis
- 9.5.3 Asia Pacific By Country Sales Analysis
- 9.5.4 China Sales Analysis
- 9.5.5 India Sales Analysis
- 9.5.6 Japan Sales Analysis
- 9.5.7 South Korea Sales Analysis
- 9.5.8 Australia Sales Analysis
- 9.5.9 South East Asia Sales Analysis
- 9.5.10 Rest Of Asia Pacific Sales Analysis
9.6. Latin America Sales Analysis
- 9.6.1 Overview, Historic and Forecast Data Sales Analysis
- 9.6.2 Latin America By Segment Sales Analysis
- 9.6.3 Latin America By Country Sales Analysis
- 9.6.4 Brazil Sales Analysis
- 9.6.5 Argentina Sales Analysis
- 9.6.6 Peru Sales Analysis
- 9.6.7 Chile Sales Analysis
- 9.6.8 Rest of Latin America Sales Analysis
9.7. Middle East & Africa Sales Analysis
- 9.7.1 Overview, Historic and Forecast Data Sales Analysis
- 9.7.2 Middle East & Africa By Segment Sales Analysis
- 9.7.3 Middle East & Africa By Country Sales Analysis
- 9.7.4 Saudi Arabia Sales Analysis
- 9.7.5 UAE Sales Analysis
- 9.7.6 Israel Sales Analysis
- 9.7.7 South Africa Sales Analysis
- 9.7.8 Rest Of Middle East And Africa Sales Analysis

10. COMPETITIVE LANDSCAPE OF THE ANTIVIRAL DRUGS COMPANIES

10.1. Antiviral Drugs Market Competition
10.2. Partnership/Collaboration/Agreement
10.3. Merger And Acquisitions
10.4. New Product Launch
10.5. Other Developments

11. COMPANY PROFILES OF ANTIVIRAL DRUGS INDUSTRY

11.1. Top Companies Market Share Analysis
11.2. Market Concentration Rate
11.3. F. Hoffmann-La Roche Ltd.
- 11.3.1 Company Overview
- 11.3.2 Company Revenue
- 11.3.3 Products
- 11.3.4 Recent Developments
11.4. GSK Plc
- 11.4.1 Company Overview
- 11.4.2 Company Revenue
- 11.4.3 Products
- 11.4.4 Recent Developments
11.5. AbbVie Inc.
- 11.5.1 Company Overview
- 11.5.2 Company Revenue
- 11.5.3 Products
- 11.5.4 Recent Developments
11.6. Merck & Co. Inc.
- 11.6.1 Company Overview
- 11.6.2 Company Revenue
- 11.6.3 Products
- 11.6.4 Recent Developments
11.7. Johnson & Johnson Services Inc.
- 11.7.1 Company Overview
- 11.7.2 Company Revenue
- 11.7.3 Products
- 11.7.4 Recent Developments
11.8. Bristol-Myers Squibb Company
- 11.8.1 Company Overview
- 11.8.2 Company Revenue
- 11.8.3 Products
- 11.8.4 Recent Developments
11.9. Cipla Inc.
- 11.9.1 Company Overview
- 11.9.2 Company Revenue
- 11.9.3 Products
- 11.9.4 Recent Developments
11.10. Aurobindo Pharma
- 11.10.1 Company Overview
- 11.10.2 Company Revenue
- 11.10.3 Products
- 11.10.4 Recent Developments
11.11. Dr. Reddy'S Laboratories Ltd
- 11.11.1 Company Overview
- 11.11.2 Company Revenue
- 11.11.3 Products
- 11.11.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies